Inactive Instrument

Company Nunzia Pharmaceutical Corporation Other OTC

Equities

NUNZ

US67097W1027

Pharmaceuticals

Business Summary

Nunzia Pharmaceutical Corporation is a pharmaceutical company. The Company focuses on development and delivery of pharmaceutical and nutraceutical-based therapies for the behavioral symptoms of Autistic Spectrum of Disorders (ASDs) and related conditions, such as Fragile X syndrome, as well as common anxiety-based disorders. The Company has developed NUNZIA, which is a combination of 16 vitamins, minerals and herbs which directly focuses and targets the hippocampus area of the brain, where all anxiety-based disorders originate.

Managers

Managers TitleAgeSince
Chief Executive Officer 51 -
President 68 01/09/01
Chief Tech/Sci/R&D Officer 62 05/19/05

Members of the board

Members of the board TitleAgeSince
President 68 01/09/01
Chief Tech/Sci/R&D Officer 62 05/19/05
Chief Executive Officer 51 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 51,000 0 0 18.04 %
Stock B 1 434,514,578 78,406,578 ( 18.04 %) 0

Company contact information

Nunzia Pharmaceutical Corp.

1627 West 14th Street

90813, Long Beach

+714 609 9117

address Nunzia Pharmaceutical Corporation(NUNZ)
  1. Stock Market
  2. Equities
  3. NUNZ Stock
  4. NUNZ Stock
  5. Company Nunzia Pharmaceutical Corporation